163 related articles for article (PubMed ID: 11419173)
21. [Diagnostic value of preoperative contrast-enhanced MR imaging of the breast].
Winnekendonk G; Krug B; Warm M; Göhring UJ; Mallmann P; Lackner K
Rofo; 2004 May; 176(5):688-93. PubMed ID: 15122467
[TBL] [Abstract][Full Text] [Related]
22. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of vascularity in breast tumors--comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging].
Schröder RJ; Bostanjoglo M; Hidajat N; Rademaker J; Röttgen R; Mäurer J; Felix R
Rofo; 2002 Sep; 174(9):1132-41. PubMed ID: 12221572
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of benign versus malignant breast disease.
Ellis RL
Radiology; 1999 Mar; 210(3):878-80. PubMed ID: 10207498
[No Abstract] [Full Text] [Related]
25. Color Doppler imaging of fibroadenomas of the breast with histopathologic correlation.
Strano S; Gombos EC; Friedland O; Mozes M
J Clin Ultrasound; 2004 Sep; 32(7):317-22. PubMed ID: 15293297
[TBL] [Abstract][Full Text] [Related]
26. Contrast-enhanced cone-beam breast-CT: Analysis of optimal acquisition time for discrimination of breast lesion malignancy.
Uhlig J; Fischer U; Surov A; Lotz J; Wienbeck S
Eur J Radiol; 2018 Feb; 99():9-16. PubMed ID: 29362157
[TBL] [Abstract][Full Text] [Related]
27. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
[TBL] [Abstract][Full Text] [Related]
28. [Prospective analysis of quantification of contrast media enhanced power Doppler sonography of equivocal breast lesions].
Pudszuhn A; Marx Ch; Malich A; Fleck M; Schneider A; Kaiser WA
Rofo; 2003 Apr; 175(4):495-501. PubMed ID: 12677504
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of tumor angiogenesis with contrast-enhanced dynamic magnetic resonance mammography.
Tuncbilek N; Unlu E; Karakas HM; Cakir B; Ozyilmaz F
Breast J; 2003; 9(5):403-8. PubMed ID: 12968962
[TBL] [Abstract][Full Text] [Related]
30. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
31. Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
Siewert C; Oellinger H; Sherif HK; Blohmer JU; Hadijuana J; Felix R
MAGMA; 1997 Mar; 5(1):29-31. PubMed ID: 9219176
[TBL] [Abstract][Full Text] [Related]
32. Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer.
Wright H; Listinsky J; Quinn C; Rim A; Crowe J; Kim J
Am J Surg; 2005 Oct; 190(4):576-9. PubMed ID: 16164924
[TBL] [Abstract][Full Text] [Related]
33. [Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography].
Knopp MV; Hoffmann U; Brix G; Hawighorst H; Junkermann HJ; van Kaick G
Radiologe; 1995 Dec; 35(12):964-72. PubMed ID: 8584640
[TBL] [Abstract][Full Text] [Related]
34. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A
Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506
[TBL] [Abstract][Full Text] [Related]
35. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
36. Contrast-enhanced ultrasonography in diagnosis of benign and malignant breast lesions.
Wang XY; Kang LK; Lan CY
Eur J Gynaecol Oncol; 2014; 35(4):415-20. PubMed ID: 25118483
[TBL] [Abstract][Full Text] [Related]
37. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
[TBL] [Abstract][Full Text] [Related]
38. [Values of color Doppler flow imaging and imaging changes of breast fascia and ligament in differential diagnosis of small breast neoplasms].
Zeng H; Zhao YL; Huang Y; Lin X; Chen XY; Li AH
Ai Zheng; 2006 Mar; 25(3):339-42. PubMed ID: 16536990
[TBL] [Abstract][Full Text] [Related]
39. Dynamic contrast-enhanced MRI reveals the extent and the microvascular pattern of breast ductal carcinoma in situ.
Santamaría G; Velasco M; Farrús B; Caparrós FX; Fernández PL
Breast J; 2013; 19(4):402-10. PubMed ID: 23758454
[TBL] [Abstract][Full Text] [Related]
40. Optical mammography: a new technique for visualizing breast lesions in women presenting non palpable BIRADS 4-5 imaging findings: preliminary results with radiologic-pathologic correlation.
Athanasiou A; Vanel D; Fournier L; Balleyguier C
Cancer Imaging; 2007 Feb; 7(1):34-40. PubMed ID: 17339139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
